The long range goal of this project is to clarify the roles played by fibrinogen and fibrin in the hemostatic process. In order to contribute to this objective, we will investigate the mechanism of fibrinogen conversion to fibrin and the clot assembly process including: fibrin fibril formation, branching and lateral association, and fibrin crosslinking (Aim 1). We expect to determine the location of the factor XIII binding site in fibrinogen, and learn how thrombin interacts with its substrate fibrinogen, and with fibrin to regulate fibrin generation, fibrin assembly, and the activation of factor XIII (Aim 2). We also wish to study congenital fibrinogen abnormalities associated with thromboembolic or hemmorhagic disorders (Aim 3), since structural and functional analysis of such dysfibrinogenemias will lead to a better understanding of the functional domains of normal fibrinogen and fibrin. To achieve these goals, we will exploit several recent discoveries on fibrin branching and crosslinking, and thrombin binding and interaction with fibrin, in developing our experimental strategies to these questions. We will employ a variety of methods including biochemical, immunological, biophysical, electron microscopic, and molecular biological techniques. Information forthcoming from these investigations will contribute to a more comprehensive understanding of the normal physiological functions of thrombin, factor XIII, fibrinogen and fibrin in hemostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL047000-01
Application #
3366184
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1991-09-01
Project End
1995-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Sinai Samaritan Medical Center Milwaukee
Department
Type
DUNS #
City
Milwaukee
State
WI
Country
United States
Zip Code
53201
Siebenlist, K R; Mosesson, M W; Meh, D A et al. (2000) Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). Blood Coagul Fibrinolysis 11:293-304
Siebenlist, K R; Meh, D A; Mosesson, M W (2000) Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures. Biochemistry 39:14171-5
Mosesson, M W; Siebenlist, K R; Voskuilen, M et al. (1998) Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Thromb Haemost 79:796-801
Mosesson, M W; Siebenlist, K R; Meh, D A et al. (1998) The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains. Proc Natl Acad Sci U S A 95:10511-6
Gailit, J; Clarke, C; Newman, D et al. (1997) Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res 232:118-26
Siebenlist, K R; Mosesson, M W (1996) Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen. Biochemistry 35:5817-21
Mosesson, M W; Siebenlist, K R; Hainfeld, J f et al. (1996) The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the ""Dusart syndrome"". J Clin Invest 97:2342-50
Siebenlist, K R; Meh, D A; Mosesson, M W (1996) Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 35:10448-53
Meh, D A; Siebenlist, K R; Mosesson, M W (1996) Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem 271:23121-5
Siebenlist, K R; Meh, D A; Wall, J S et al. (1995) Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa. Thromb Haemost 74:1113-9

Showing the most recent 10 out of 25 publications